NESP Pediatric Study

NCT00527137 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Pre-dialysis
End Stage Renal Disease

Interventions

DRUG: darbepoetin alfa
DRUG: rHuEPO

Sponsor

Amgen